MikroScore
Science-backed ingredient evidence
Weak Evidence Safety: Likely safe Study dose: 500 mg/day

Fucoidan

Also known as: Fucoidane, Brown Seaweed Extract, Braunalgen-Extrakt, Undaria pinnatifida Extract, Fucus vesiculosus Extract, Oligo-Fucoidan, OliFuco

Summary Weak Evidence

Fucoidan is a sulfated polysaccharide from brown seaweed with growing evidence for prebiotic gut effects, muscle health, and cardiovascular markers.

EU Health Claims: No approved claims

No approved EU health claims for fucoidan. Brown seaweed extracts may be classified as novel foods under Regulation (EU) 2015/2283, in which case EFSA authorisation is required before they can be marketed as supplements.

AI Summary

Quick verdict

Fucoidan is a sulfated polysaccharide from brown seaweed with growing evidence for prebiotic gut effects, muscle health, and cardiovascular markers.

What the evidence supports

Multiple RCTs show positive effects on gut microbiome (prebiotic), grip strength in older adults, and muscle strength during resistance training. Moderate evidence for cardiovascular markers (LDL, blood pressure).

What is NOT supported

Clinical human trials are absent or very weak. Long-term safety in humans is largely unexplored.

EU/EFSA status

Not approved. No approved EU health claims for fucoidan. Brown seaweed extracts may be classified as novel food…

Safety

Likely safe

This AI summary is generated from the structured data on this page.

How It Works

Fucoidan is a sulfated polysaccharide derived from brown seaweeds including Undaria pinnatifida (wakame), Fucus vesiculosus (bladderwrack), Saccharina latissima, and Cladosiphon okamuranus (mozuku). It is fundamentally different from sea moss (a red alga): fucoidan has a defined sulfated polysaccharide structure with specific biological activities.

Proposed mechanisms include:

  • Prebiotic effect: Promoting Bifidobacterium and Faecalibacterium, strengthening gut barrier integrity (tight junctions)
  • Immunomodulation: Activation of NK cells and macrophages, modulation of pro-inflammatory cytokines
  • Musculoskeletal support: Prebiotic and direct mechanisms that may support muscle strength and lean body mass
  • Cardiovascular effects: Modest effects on LDL cholesterol and diastolic blood pressure
  • Anti-inflammatory: NF-κB inhibition and reduction of pro-inflammatory cytokines

Evidence Base

Fucoidan has a growing clinical evidence base — unusual for an algae-derived ingredient.

Gut Health and Microbiome (Strongest Evidence)

A three-arm double-blind RCT (2025, Microorganisms) using a fucoidan-rich Saccharina latissima extract demonstrated significant prebiotic effects: dose-dependent increases in Bifidobacterium and Faecalibacterium, improved microbial diversity, and gut barrier strengthening. This is among the methodologically strongest fucoidan evidence to date.

Muscle Function and Physical Performance

A parallel RCT (Sci Rep 2025) examining fucoidan supplementation combined with 6 weeks of resistance training found significantly higher peak power and improved lean body mass in the fucoidan group vs. training alone. A separate 12-week double-blind RCT (Archives of Gerontology and Geriatrics 2025) using oligo-fucoidan (OliFuco RE) showed significant improvements in grip strength in community-dwelling older adults — both statistically and clinically meaningful.

Digestive and Mental Wellbeing (Early Data)

A 28-day RCT with Thalivra (purified fucoidan extract, INNOSea study, Aberystwyth University 2026) showed promising effects on digestive health and subjective wellbeing in young adults. Formal publication pending.

Cardiovascular Markers

Reviews and smaller RCTs show moderate, consistent effects on diastolic blood pressure and LDL cholesterol. Evidence strength: moderate.

Anti-Cancer Claims

Anti-cancer claims are based exclusively on preclinical in vitro and animal data. Not established in humans for supplement use. A Phase 2 trial on chemo-related fatigue is currently recruiting.

Important Product Differences

Not all fucoidan products are equivalent: the source alga, extraction method, molecular weight, and degree of sulfation significantly affect biological activity. Products with standardised fucose content or defined molecular weight fractions (e.g. oligo-fucoidan) are more comparable than generic “brown seaweed extract” labels.

Safety

Fucoidan is generally well tolerated. No serious adverse effects have been reported in clinical trials. Key considerations:

  • Anticoagulant properties: Structural similarity to heparin — caution with blood thinners (warfarin, apixaban, heparin)
  • Iodine content: Varies by seaweed source — relevant with thyroid conditions
  • Pregnancy: Insufficient safety data

Dosage

  • Typical range: 250–1,000 mg fucoidan extract per day
  • Used in RCTs: 250–500 mg per day
  • Oligo-fucoidan (grip strength RCT): Manufacturer-specific dose

Standardisation to fucose content or degree of sulfation is desirable but not always stated on product labels.

Key Studies

Gut Microbiome Modulation and Health Benefits of a Novel Fucoidan Extract from Saccharina latissima: A Double-Blind, Placebo-Controlled Trial

Various (2025)

Three-arm double-blind RCT (n=90, 4 weeks): fucoidan-rich extract from Saccharina latissima significantly increased beneficial gut bacteria (Bifidobacterium, Faecalibacterium) in a dose-dependent manner. Improved gut barrier and microbial diversity. Clinically relevant evidence for prebiotic mechanism.

PubMed PMID 40732054

Investigating fucoidan blend supplementation and resistance training in humans: a parallel randomized controlled trial design

Various (2025) n=20

Parallel RCT (Sci Rep 2025): fucoidan blend supplementation during 6 weeks of resistance training significantly increased peak power and lean body mass vs. training alone. Lower body strength improved in both groups. Suggests potential anabolic potentiation effect.

PubMed PMID 41249370
Editorial notice: For most ingredients described here, no health claims are approved in the EU (Regulation (EC) 1924/2006). Evidence levels are editorial assessments of research quality — not health promises. This content is not a substitute for medical advice and does not constitute a recommendation to treat, alleviate, or prevent any disease.